OncoCyte Corporation
OCX
$2.73
$0.083.02%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 259.30% | 156.79% | -63.67% | 65.94% | -40.86% |
| Total Receivables | 119.47% | 671.77% | 145.88% | -47.20% | -66.74% |
| Inventory | 11.95% | 76.72% | -- | -- | -- |
| Prepaid Expenses | 50.43% | 30.94% | 5.38% | -19.05% | 14.31% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -22.93% | 1,031.25% | -47.54% | -56.12% |
| Total Current Assets | 208.39% | 145.34% | -51.92% | 52.53% | -38.91% |
|
|
|||||
| Total Current Assets | 208.39% | 145.34% | -51.92% | 52.53% | -38.91% |
| Net Property, Plant & Equipment | 13.14% | -2.63% | 9.38% | 3.68% | 5.35% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -0.05% | -74.16% | -0.04% | -0.04% | -0.04% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -2.05% | -0.33% | 6.01% | 5.85% | -1.16% |
| Total Assets | 72.06% | -50.04% | -6.03% | 5.28% | -5.23% |
|
|
|||||
| Total Accounts Payable | 0.00% | 161.35% | -17.03% | 15.75% | -4.72% |
| Total Accrued Expenses | 60.29% | -13.33% | 42.90% | -34.55% | 33.17% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 8.42% | 0.94% | 24.68% | 25.33% | 23.46% |
| Total Finance Division Other Current Liabilities | 89.91% | -92.21% | 26.53% | 0.00% | -1.91% |
| Total Other Current Liabilities | 89.91% | -92.21% | 26.53% | 0.00% | -1.91% |
| Total Current Liabilities | 33.10% | -19.97% | 26.29% | -13.56% | 15.75% |
|
|
|||||
| Total Current Liabilities | 33.10% | -19.97% | 26.29% | -13.56% | 15.75% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -12.45% | -12.52% | 2.65% | 4.93% | 14.07% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 1.79% | -22.58% | 15.47% | -2.39% | 8.30% |
| Total Liabilities | 5.89% | -21.73% | 16.32% | -3.77% | 9.65% |
|
|
|||||
| Common Stock & APIC | 8.62% | 3.54% | 0.15% | 5.04% | 0.08% |
| Retained Earnings | -1.90% | -10.57% | -4.45% | -1.52% | -3.15% |
| Treasury Stock & Other | 95.24% | -63.16% | 54.05% | -7.50% | -18.37% |
| Total Common Equity | 183.25% | -226.39% | -57.23% | 95.92% | -43.38% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | 4.02% |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | 4.02% |
|
|
|||||
| Total Common Equity | 183.25% | -226.39% | -57.23% | 95.92% | -43.38% |
| Total Preferred Equity | -- | -- | -- | -- | 4.02% |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 183.25% | -226.39% | -57.23% | 34.18% | -33.89% |
|
|
|||||